Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Ross

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Current Opinion in Oncology|February 1, 1991
Cellular and pharmacologic aspects of drug resistance in acute myeloid leukemiaD D Ross
Leukemia|March 17, 2000
Novel mechanisms of drug resistance in leukemiaD D Ross
Anticancer Research|August 26, 1998
Biochemical and clinical aspects of efflux pump related resistance to anti-cancer drugsA Aszalos, D D Ross
Seminars in Oncology|August 1, 1995
Consequences of 2',2'-difluorodeoxycytidine (gemcitabine) on replicative DNA synthesis in intact HL-60 cellsD D Ross, D P Cuddy
Biochemical Pharmacology|October 18, 1994
Molecular effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on DNA replication in intact HL-60 cellsD D Ross, D P Cuddy
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 8, 1999
Palliative care education--can we respond to the challenge?P A Seligman, D D Ross
American Family Physician|October 2, 2001
Management of common symptoms in terminally ill patients: Part II. Constipation, delirium and dyspneaD D Ross, C S Alexander
American Family Physician|September 21, 2001
Management of common symptoms in terminally ill patients: Part I. Fatigue, anorexia, cachexia, nausea and vomitingD D Ross, C S Alexander
Archives of Internal Medicine|April 1, 1979
Tamoxifen in advanced male breast cancerJ Aisner, D D Ross, P H Wiernik
Cancer Research|May 1, 1990
Effects of 1-beta-D-arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elutionD D Ross, S R Chen, D P Cuddy
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Current Opinion in Oncology|February 1, 1991
Cellular and pharmacologic aspects of drug resistance in acute myeloid leukemiaD D Ross
Leukemia|March 17, 2000
Novel mechanisms of drug resistance in leukemiaD D Ross
Anticancer Research|August 26, 1998
Biochemical and clinical aspects of efflux pump related resistance to anti-cancer drugsA Aszalos, D D Ross
Seminars in Oncology|August 1, 1995
Consequences of 2',2'-difluorodeoxycytidine (gemcitabine) on replicative DNA synthesis in intact HL-60 cellsD D Ross, D P Cuddy
Biochemical Pharmacology|October 18, 1994
Molecular effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on DNA replication in intact HL-60 cellsD D Ross, D P Cuddy
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 8, 1999
Palliative care education--can we respond to the challenge?P A Seligman, D D Ross
American Family Physician|October 2, 2001
Management of common symptoms in terminally ill patients: Part II. Constipation, delirium and dyspneaD D Ross, C S Alexander
American Family Physician|September 21, 2001
Management of common symptoms in terminally ill patients: Part I. Fatigue, anorexia, cachexia, nausea and vomitingD D Ross, C S Alexander
Archives of Internal Medicine|April 1, 1979
Tamoxifen in advanced male breast cancerJ Aisner, D D Ross, P H Wiernik
Cancer Research|May 1, 1990
Effects of 1-beta-D-arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elutionD D Ross, S R Chen, D P Cuddy
Pageof 7